Difficulty: Medium
Average Score: 82%
Practice
The aminoglycoside antibiotic which is distinguished by its resistance to bacterial aminoglycoside inactivating enzymes is
Correct answer
C
Rationale
The correct answer is C) Amikacin. In the context of aminoglycoside antibiotics, amikacin is distinguished by its resistance to bacterial aminoglycoside inactivating enzymes. This property makes amikacin particularly effective against bacteria that produce these enzymes, allowing it to maintain its antibacterial activity where other aminoglycosides might be rendered ineffective.
Looking at the other options:
A) Kanamycin is susceptible to inactivation by bacterial enzymes.
B) Sisomicin is also susceptible to inactivation by bacterial enzymes.
D) Tobramycin, like kanamycin and sisomicin, can be inactivated by bacterial enzymes.
Understanding the unique characteristics of each aminoglycoside antibiotic is crucial in clinical practice to ensure the selection of the most appropriate drug for a specific bacterial infection. By knowing that amikacin is resistant to bacterial inactivating enzymes, healthcare providers can make more informed decisions when prescribing antibiotics to treat infections caused by resistant strains of bacteria. This knowledge can contribute to better patient outcomes and help combat the issue of antibiotic resistance.
Looking at the other options:
A) Kanamycin is susceptible to inactivation by bacterial enzymes.
B) Sisomicin is also susceptible to inactivation by bacterial enzymes.
D) Tobramycin, like kanamycin and sisomicin, can be inactivated by bacterial enzymes.
Understanding the unique characteristics of each aminoglycoside antibiotic is crucial in clinical practice to ensure the selection of the most appropriate drug for a specific bacterial infection. By knowing that amikacin is resistant to bacterial inactivating enzymes, healthcare providers can make more informed decisions when prescribing antibiotics to treat infections caused by resistant strains of bacteria. This knowledge can contribute to better patient outcomes and help combat the issue of antibiotic resistance.